---

$125.10

+3.4140 ( +2.81% ) 612.9K

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Open	$125.10
Previous Close	$121.69
Volume	612.9K
Market Cap	$7.15B
Day Range	$120.72 - $127.89
52 Week Range	$73.16 - $148.11
Shares Outstanding	58.73M
Change %	+2.81%
Net Change	▲ 3.4140
Insider Ownership	N/A
Exchange	NYSE
Sector	Industrials
Industry	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
IPO Year	2015
Country	United States
Underwriter	IPO Intelligence Only

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
No records found.